Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma

NCT00738582 is registered in ClinicalTrials.gov with Morphotek as lead sponsor.

NCT NCT00738582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00738582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Lead sponsor
Morphotek
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2008
Completion date
January 10, 2014
Enrollment
89 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural mesothelioma